Current Active Clinical Trials:

Trial 1: Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM (Protocol AM)

Objective: Compare visual acuity outcomes at 36 months between eyes randomized to immediate versus deferred surgery.

Trial 2: Randomized Trial of Intravitreal OTX-TKI (Axitinib Implant) for Non-Proliferative Diabetic Retinopathy (NPDR) (HELIOS-3)

Objective: To evaluate the efficacy and safety of intravitreal (IVT) OTX-TKI (0.45 mg axitinib implant) in participants with NPDR.

If you have any questions or want to learn more about the current ongoing trials, call our office at 818-552-5040 / 310-659-2200 and ask to speak with our Clinical Research Coordinator.